Post-approval studies (Phase 4)Study completedNCT00911625
What this trial is testing
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Who this might be right for
Type 2 DiabetesRenal Insufficiency
Loyola University 114